Cargando…
Sacubitril/valsartan in the treatment of systemic right ventricular failure
OBJECTIVE: Pharmacological options for patients with a failing systemic right ventricle (RV) in the context of transposition of the great arteries (TGA) after atrial switch or congenitally corrected TGA (ccTGA) are not well defined. This study aims to investigate the feasibility and effects of sacub...
Autores principales: | Zandstra, Tjitske E, Nederend, Marieke, Jongbloed, Monique R M, Kiès, Philippine, Vliegen, Hubert W, Bouma, Berto J, Tops, Laurens F, Schalij, Martin J, Egorova, Anastasia D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522462/ https://www.ncbi.nlm.nih.gov/pubmed/33452121 http://dx.doi.org/10.1136/heartjnl-2020-318074 |
Ejemplares similares
-
The first experience with sodium‐glucose cotransporter 2 inhibitor for the treatment of systemic right ventricular failure
por: Egorova, Anastasia D., et al.
Publicado: (2022) -
Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure
por: Nederend, Marieke, et al.
Publicado: (2021) -
Atrioventricular Block Necessitating Chronic Ventricular Pacing After Tricuspid Valve Surgery in Patients With a Systemic Right Ventricle: Long-Term Follow-Up
por: Nederend, Marieke, et al.
Publicado: (2022) -
Asymmetry and Heterogeneity: Part and Parcel in Cardiac Autonomic Innervation and Function
por: Zandstra, Tjitske E., et al.
Publicado: (2021) -
The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart disease
por: Neijenhuis, Ralph M. L., et al.
Publicado: (2023)